Founded in 2000, TEMIS helps organisations structure, manage and leverage their unstructured information assets. Luxid®, its flagship platform, extracts structured information from unstructured content and semantically enriches content with domain-specific metadata. This enables organisations not only to intelligently archive, manage, analyse, discover and share increasing volumes of information, but also to maximise the efficiency of their intensive Big Data analysis and discovery tasks such as business intelligence, customer voice and social media analysis and scientific discovery.
The Exclusive Networks group provides a link for up-and-coming, fast-growing technology vendors from around the world to the EMEA region’s markets through its SuperVAD value-added distribution model. As a specialist provider of security, networking, infrastructure and storage solutions for the smart social enterprise, the Exclusive Networks group works with over 4,600 partner VARs.
uniQure purchased the assets of AMT in April 2012, making it one of the world leaders in gene therapy research and development. Its Glybera® product is the first gene therapy drug to have gained marketing approval in Europe, and is used to treat adult patients diagnosed with familial lipoprotein lipase deficiency (LPLD), a rare condition in which patients do not have the gene for an enzyme responsible for breaking down fats.
uniQure is developing products to treat various other conditions such as Haemophilia B, acute intermittent porphyria (AIP) and Parkinson’s disease.
February 2014: uniQure (QURE) successfully completed its IPO on the Nasdaq, raising $82 million.
Market capitalisation at IPO date: $300 million
Headquartered in Saint-Ouen-l’Aumône (Val d’Oise department), the Pommier group designs, manufactures and distributes equipment and accessories for industrial vehicle bodywork. It is the leading player in the French market and has production and distribution facilities in France and Europe.
The Salins group has production facilities in France, Spain, Italy and Africa. It is the only European producer with expertise in the three different salt production techniques–agricultural (sea salt), industrial (refined salt) and mining (rock salt). Its activities are fully integrated (from production through to distribution) and highly diversified (ranging from a 125g box of Camargue flower salt, to a bulk shipment of 30,000 tonnes).
CPC, which has 9 plants and a workforce of around 800 employees, offers an extensive range of labelling and packaging solutions.
Compin designs and delivers turnkey solutions for mass transit operators and equipment manufacturers. Compin is one of the top European players in the rail and bus seat market. It has installed over 5 million seats and installs or renovates tens of thousands of seats every year.
After arranging the mezzanine debt in the primary leveraged buy-out (LBO) of Compin led by LBO France, Mezzanis arranged the mezzanine financing for the secondary LBO led by Barclays Private Equity in March 2009.
SCT is one of France’s leading providers of telecoms solutions for SMEs and micro-companies and offers a full range of telephony services (service reselling, unbundling, VoIP, MVNO) via its network of branches across France. Mezzanis co-arranged the €10 million in mezzanine financing put in place during October 2007 to fund Astorg Partners’ leveraged buy-out (LBO) of SCT together with the group’s founders and management.
Established at Vire (Calvados department) since its inception in 1976, the Legoupil Industrie group specialises in the design, manufacture, rental and sale of industrial buildings and modular constructions for storage and production purposes. The group has also developed an interior furnishing and fittings business. Its customers consist predominantly of industrial companies, major groups and SMEs, as well as service companies and local authorities.